Treatment outcome of clonal cytopenias of undetermined significance: a single-institution retrospective study

[1]  P. Campbell,et al.  SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS , 2020, Blood.

[2]  P. Campbell,et al.  SF3B1-mutant myelodysplastic syndrome as a distinct disease subtype - A Proposal of the International Working Group for the Prognosis of Myelodysplastic Syndromes (IWG-PM). , 2020, Blood.

[3]  Cytopenia , 2020, Definitions.

[4]  Daniel J. Devine,et al.  Hybridization capture-based next generation sequencing reliably detects FLT3 mutations and classifies FLT3-internal tandem duplication allelic ratio in acute myeloid leukemia: a comparative study to standard fragment analysis , 2019, Modern Pathology.

[5]  D. Steensma Clinical Implications of Clonal Hematopoiesis , 2018, Mayo Clinic proceedings.

[6]  M. Cazzola,et al.  Clinical significance of somatic mutation in unexplained blood cytopenia. , 2017, Blood.

[7]  R. Bejar CHIP, ICUS, CCUS and other four-letter words , 2017, Leukemia.

[8]  S. Barrans,et al.  Targeted sequencing identifies patients with preclinical MDS at high risk of disease progression. , 2015, Blood.

[9]  J. Witte,et al.  MDS-associated somatic mutations and clonal hematopoiesis are common in idiopathic cytopenias of undetermined significance. , 2015, Blood.

[10]  B. Ebert,et al.  Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. , 2015, Blood.

[11]  Joshua F. McMichael,et al.  Age-related cancer mutations associated with clonal hematopoietic expansion , 2014, Nature Medicine.

[12]  C. Franceschi,et al.  Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[13]  B. Cheson,et al.  Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. , 2006, Blood.